Leading pharmaceutical company enhancing health in Asia-Pacific. Menarini Asia-Pacific (Menarini APAC) is a fully owned regional subsidiary of Italy’s Menarini Group with its headquarters located in Singapore. Since becoming operational in 2011 after the acquisition of Invida Group, the company now serves 13 key markets across the Asia-Pacific region. Menarini APAC offers a broad portfolio covering pharmaceuticals and consumer health across dermatology, allergy/respiratory, gastroenterology, cardio-metabolic, anti-infectives, oncology, and men's health. They cover the entire commercial value chain, from clinical development and regulatory approval to product launch and lifecycle management, continuously investing in R&D and manufacturing capabilities specific for the region. Menarini APAC employs over 3,000 people and collaborates with partners to bring innovative and essential medicines to patients. Recent financial details are not publicly disclosed.